StockData
U S Physical Therapy Inc logo

U S Physical Therapy Inc (USPH) stock

USPHNYSEServices-Health ServicesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 10/307% above fair value
$85.83−0.74 (-0.85%)

Close on Oct 30, 2026Market cap $1.28BP/E –Yield 2.10%

Earnings

U S Physical Therapy's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
Nov 5, 2026
Q3 FY2026 · estimated, after the close
Revenue, Q2 FY2026
$214.10M
+8.5% on a year earlier
operating results per share, Q2 FY2026
$0.75
$0.81 a year earlier
Latest guidance
Reaffirmed
Aug 6, 2026 · 1 item

Quarterly results

Revenue and earnings per share from each of U S Physical Therapy's earnings releases, newest first

QuarterReportedRevenueYoYEPSAdj. EPSSource
Q3 FY2026ended Sep 30, 2026Nov 5, 2026Expected–––––
Q2 FY2026ended Jun 30, 2026Aug 6, 2026after the close$214.10M+8.5%$0.25$0.75Release
Q1 FY2026ended Mar 31, 2026May 6, 2026after the close$198.30M+7.9%-$0.12$0.46Release
Q3 FY2025ended Sep 30, 2025Nov 6, 2025after the close$197.13M–$0.48$0.66Release
Q2 FY2025ended Jun 30, 2025Aug 7, 2025before the open$197.34M–$0.58$0.81Release
Q1 FY2025ended Mar 31, 2025May 7, 2025after the close$183.79M–$0.80$0.48Release
Q4 FY2023ended Dec 31, 2023Feb 28, 2024after the close$154.80M+9.6%-$0.38$0.59Release
Q3 FY2023ended Sep 30, 2023Nov 8, 2023after the close$150.00M+7.4%$0.51$0.62Release
Q2 FY2023ended Jun 30, 2023Aug 9, 2023during market hours$151.50M+7.7%$0.64$0.76Release
Q1 FY2023ended Mar 31, 2023May 5, 2023during market hours$148.50M+12.8%$0.58$0.59Release
Q4 FY2022ended Dec 31, 2022Feb 23, 2023during market hours$141.20M+8.8%-$0.01$0.58Release
Q3 FY2022ended Sep 30, 2022Nov 2, 2022after the close$139.60M+10.9%$0.72$0.58Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Current guidance

U S Physical Therapy's latest outlook for periods it has not reported yet, compared with what it said before

MetricPeriodGuidanceBeforeChangeGiven
adjusted EBITDAnon-GAAPFY2026$102.00M – $106.00M$102.00M – $106.00MReaffirmedAug 6, 2026

Guidance history

Every forecast U S Physical Therapy put in an earnings release, newest first

GivenMetricPeriodGuidanceChange
Aug 6, 2026adjusted EBITDAFY2026$102.00M – $106.00MReaffirmed
May 6, 2026adjusted EBITDAFY2026$102.00M – $106.00MNew
Nov 6, 2025Adjusted EBITDAFY2025$93.00M – $97.00MReaffirmed
Aug 7, 2025Adjusted EBITDAFY2025$93.00M – $97.00MNew
Feb 28, 2024Adjusted EBITDAFY2024$80.00M – $85.00MNew
Nov 7, 2023Adjusted EBITDAFY2023$75.00M – $80.00MReaffirmed
Aug 9, 2023Adjusted EBITDAFY2023$75.00M – $80.00MReaffirmed
May 5, 2023Adjusted EBITDAFY2023$75.00M – $80.00MReaffirmed
Feb 23, 2023Adjusted EBITDAFY2023$75.00M – $80.00MNew
Nov 2, 2022Adjusted EBITDAFY2022$73.50M – $75.40MReaffirmed
Nov 2, 2022Operating ResultsFY2022$2.65 – $2.75Reaffirmed
Nov 2, 2022Operating ResultsFY2022$34.40M – $35.80MReaffirmed
Aug 4, 2022Adjusted EBITDAFY2022$73.50M – $75.40MNew
Aug 4, 2022Operating Results per shareFY2022$2.65 – $2.75Lowered
Aug 4, 2022Operating ResultsFY2022$34.40M – $35.80MLowered
Feb 24, 2022Operating Results per diluted shareFY2022$3.25 – $3.35New
Feb 24, 2022Operating ResultsFY2022$42.20M – $43.50MNew
Feb 24, 2022estimated annual effective tax rateFY202227.1%New
Aug 5, 2021Operating Results per diluted shareFY2021$3.05 – $3.15Raised
Aug 5, 2021estimated annual effective tax rateFY202127%Reaffirmed

Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.

Press releases

Releases U S Physical Therapy filed with the SEC as exhibits to Form 8-K or 6-K

  1. News
  2. News
  3. Update
  4. Update
  5. Results
  6. News
  7. Update
  8. Update
  9. Results
  10. Update
  11. Update
  12. Update
  13. News
  14. News
  15. News